NEW YORK (dpa-AFX) – Investors are taking it slow on Monday on Wall Street after the last strong run. They positioned themselves a little more cautiously with the standard values in the Dow Jones Industrial due to the continued smoldering uncertainty that prevails around the coronavirus variant Omikron and the unbroken high inflation. Against this background, the coming days will be dominated by monetary policy – including the Fed’s interest rate decision on Wednesday.
After its four percent plus the previous week, the Dow Jones Industrial is toying
“In view of the constant high inflation in the United States, the markets expect further signals in terms of interest rate turnaround,” said market observer Timo Emden with a view to the Fed meeting. The US Federal Reserve is expected to react to high inflation and accelerate the exit from its extremely loose stance. At the moment, however, the market is again asking to what extent Omikron could restrict its monetary policy leeway again.
For the tech-heavy Nasdaq 100
Otherwise, there were some analyst comments in the pre-market session that attracted attention. Among other things, JPMorgan is now more optimistic about the shares of Coca-Cola with an “Overweight” vote
In the pharmaceutical sector, Pfizer became
Meanwhile, Pfizer also announced an acquisition for which the pharmaceutical company is willing to pay a high premium: Arena Pharmaceuticals is to be incorporated for 6.7 billion dollars. For the shareholders of the takeover target, this means a real rain of money, the price rose by almost 90 percent before the market. Pfizer is offering $ 100 per share, twice the price on Friday when Arena shares closed at just under $ 50.
There was also a meaningful analytical voice among the technology stocks: the papers from Qualcomm
ISIN US2605661048 US6311011026 US78378X1072
Copyright dpa-AFX Wirtschaftsnachrichten GmbH. All rights reserved. Redistribution, republication or permanent storage without the express prior consent of dpa-AFX is not permitted.